Moody National Bank Trust Division reduced its stake in CVS Health Corporation (NYSE:CVS) by 0.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,347 shares of the pharmacy operator’s stock after selling 25 shares during the period. Moody National Bank Trust Division’s holdings in CVS Health Corporation were worth $1,155,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. grew its position in shares of CVS Health Corporation by 3.2% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after buying an additional 5,478 shares during the last quarter. Fiduciary Trust Co. boosted its position in shares of CVS Health Corporation by 1.2% during the first quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock valued at $28,732,000 after purchasing an additional 4,265 shares in the last quarter. British Columbia Investment Management Corp boosted its position in shares of CVS Health Corporation by 3.7% during the first quarter. British Columbia Investment Management Corp now owns 561,299 shares of the pharmacy operator’s stock valued at $44,062,000 after purchasing an additional 19,794 shares in the last quarter. Bahl & Gaynor Inc. boosted its position in shares of CVS Health Corporation by 1.1% during the first quarter. Bahl & Gaynor Inc. now owns 14,922 shares of the pharmacy operator’s stock valued at $1,171,000 after purchasing an additional 167 shares in the last quarter. Finally, Independent Advisor Alliance boosted its position in shares of CVS Health Corporation by 6.7% during the first quarter. Independent Advisor Alliance now owns 26,460 shares of the pharmacy operator’s stock valued at $2,038,000 after purchasing an additional 1,652 shares in the last quarter. 81.49% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director Richard J. Swift sold 2,500 shares of CVS Health Corporation stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total value of $199,050.00. Following the sale, the director now directly owns 3,258 shares in the company, valued at approximately $259,401.96. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Helena Foulkes sold 39,340 shares of CVS Health Corporation stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $81.88, for a total value of $3,221,159.20. Following the completion of the sale, the executive vice president now owns 84,337 shares in the company, valued at $6,905,513.56. The disclosure for this sale can be found here. In the last 90 days, insiders sold 696,078 shares of company stock valued at $56,650,631. 0.61% of the stock is owned by company insiders.

Several research firms recently weighed in on CVS. Royal Bank Of Canada began coverage on CVS Health Corporation in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target on the stock. Jefferies Group LLC lifted their price target on CVS Health Corporation from $82.00 to $86.00 and gave the company a “hold” rating in a research report on Friday, September 15th. Needham & Company LLC began coverage on CVS Health Corporation in a research report on Tuesday, June 27th. They set a “hold” rating on the stock. Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Finally, Leerink Swann set a $90.00 price target on CVS Health Corporation and gave the company a “buy” rating in a research report on Tuesday, June 27th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $90.58.

ILLEGAL ACTIVITY NOTICE: “Moody National Bank Trust Division Has $1.16 Million Holdings in CVS Health Corporation (CVS)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/10/01/moody-national-bank-trust-division-has-1-16-million-holdings-in-cvs-health-corporation-cvs.html.

CVS Health Corporation (CVS) opened at 81.32 on Friday. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $90.85. The company has a market cap of $82.67 billion, a price-to-earnings ratio of 16.20 and a beta of 0.92. The stock has a 50 day moving average price of $79.11 and a 200-day moving average price of $78.98.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion during the quarter, compared to analyst estimates of $45.36 billion. During the same quarter in the previous year, the business earned $1.32 EPS. CVS Health Corporation’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, equities research analysts forecast that CVS Health Corporation will post $5.88 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be paid a $0.50 dividend. The ex-dividend date is Monday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.46%. CVS Health Corporation’s dividend payout ratio is presently 39.92%.

CVS Health Corporation Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.